Clinical Trials Browser

Phase 1/2 × INDUSTRY × Advanced Unresectable Solid Tumors × Clear all

NCT02428712 2025-07-29

A Study of FORE8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Advanced Unresectable Solid Tumors